Literature DB >> 16393985

HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood.

Angela Granelli-Piperno1, Irina Shimeliovich, Maggi Pack, Christine Trumpfheller, Ralph M Steinman.   

Abstract

The infection of cultured monocyte-derived dendritic cells (DCs) with HIV-1 involves CD4 and CCR5 receptors, while transmission to T cells is enhanced at least in part by the lectin DC-SIGN/CD209. In the present study, we studied BDCA-1+ myeloid DCs isolated directly from human blood. These cells express CD4 and low levels of CCR5 and CXCR4 coreceptors, but not DC-SIGN. The myeloid DCs replicate two R5 viruses, BaL and YU2, and transfer infection to activated T cells. The virus productively infects a small fraction of the blood DCs that fail to mature in culture, as indicated by the maturation markers CD83 and DC-LAMP/CD208, and the expression of high CD86 and MHC class II, in contrast to many noninfected DCs. A greater proportion of BDCA-1+ DCs are infected when the virus is pseudotyped with the vesicular stomatitis envelope VSV-G (5-15%), as compared with the R5 virus (0.3-3.5%), indicating that HIV-1 coreceptors may limit the susceptibility of DCs to become infected, or the endocytic route of viral entry used by HIV/vesicular stomatitis virus enhances infectivity. When infected and noninfected cells are purified by cell sorting, the former uniformly express HIV p24 gag and are virtually inactive as stimulators of the allogeneic MLR, in contrast to potent stimulation by noninfected DCs from the same cultures. These results point to two roles for a small fraction of blood DCs in HIV-1 pathogenesis: to support productive infection and to evade the direct induction of T cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393985     DOI: 10.4049/jimmunol.176.2.991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Current concepts of HIV transmission.

Authors:  Gavin Morrow; Laurence Vachot; Panagiotis Vagenas; Melissa Robbiani
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

2.  Current concepts of HIV transmission.

Authors:  Gavin Morrow; Laurence Vachot; Panagiotis Vagenas; Melissa Robbiani
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 3.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 4.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

Review 5.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

6.  PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection.

Authors:  Timothy M Hanley; Wendy Blay Puryear; Suryaram Gummuluru; Gregory A Viglianti
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 7.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

8.  Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques.

Authors:  Benoît Malleret; Ingrid Karlsson; Benjamin Manéglier; Patricia Brochard; Benoît Delache; Thibault Andrieu; Michaela Muller-Trutwin; Tim Beaumont; Joseph M McCune; Jacques Banchereau; Roger Le Grand; Bruno Vaslin
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

Review 9.  Influence of dendritic cells on viral pathogenicity.

Authors:  Giulia Freer; Donatella Matteucci
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.